CEP55 and non-small cell lung carcinoma: In univariate analysis, CEP55 expression in patients with NSCLC was unrelated to age (HR = 0.990, 0.973 to 1.006, P = 0.224), gender (HR = 1.010, 0.712–1.433, P = 0.9555), grade (HR = 0.940, 0.741–1.193, P = 0.613), stage (HR = 0.911, 0.760–1.093, P = 0.317), T (HR = 0.915, 0.716 ~ 1.169, P = 0.475), N (HR = 0.808, 0.645 ~ 1.013, P = 0.065), M (HR = 0.985, 0.554 ~ 1.751, P = 0.960).